Bleicher I, Rossin E, Vavvas D. Reevaluating the Risk of Serious Adverse Events of Carbonic Anhydrase Inhibitors. JAMA Ophthalmol. 2022;140(7):745–746. See also: Glaucoma, July 2022, All, 2022 Last updated on 03/06/2023
